Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
This is an increase over the number of companies cited in the previous year.
Of the 18 citations issued, the most common citations include:
- The quality control unit lacks authority to review production records to assure that no errors have occurred.
- Buildings used in the manufacture, processing, packing, or holding of a drug product do not have the suitable construction to facilitate cleaning, maintenance, and proper operations.
- Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room and equipment to produce aseptic conditions.
All of the companies cited were involved in either Food and Cosmetics, Biologics, Drugs, or Devices sectors.
All of the companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Pharmacia & Upjohn Company, LLC | Biologics | 06/16/2023 | Authority lacking to review records, investigate errors |
Pharmacia & Upjohn Company, LLC | Biologics | 06/16/2023 | Buildings of Suitable Size, Construction, Location |
Pharmacia & Upjohn Company, LLC | Biologics | 06/16/2023 | Cleaning System |
Pharmacia & Upjohn Company, LLC | Biologics | 06/16/2023 | Sanitation--buildings not clean, free of infestation |
Pharmacia & Upjohn Company, LLC | Biologics | 06/16/2023 | Equipment Design, Size and Location |
Pharmacia & Upjohn Company, LLC | Biologics | 06/16/2023 | Absence of Written Procedures |
Pharmacia & Upjohn Company, LLC | Biologics | 06/16/2023 | Validation lacking for sterile drug products |
Pharmacia & Upjohn Company, LLC | Drugs | 06/16/2023 | Authority lacking to review records, investigate errors |
Pharmacia & Upjohn Company, LLC | Drugs | 06/16/2023 | Buildings of Suitable Size, Construction, Location |
Pharmacia & Upjohn Company, LLC | Drugs | 06/16/2023 | Cleaning System |
Pharmacia & Upjohn Company, LLC | Drugs | 06/16/2023 | Sanitation--buildings not clean, free of infestation |
Pharmacia & Upjohn Company, LLC | Drugs | 06/16/2023 | Equipment Design, Size and Location |
Pharmacia & Upjohn Company, LLC | Drugs | 06/16/2023 | Absence of Written Procedures |
Pharmacia & Upjohn Company, LLC | Drugs | 06/16/2023 | Validation lacking for sterile drug products |
Stryker Corporation | Devices | 01/24/2023 | Design validation- Lack of or inadequate procedures |
Stryker Corporation | Devices | 01/24/2023 | Lack of or inadequate complaint procedures |
Water Street Coffee Joint | Food and Cosmetics | 06/07/2023 | Grounds |
Water Street Coffee Joint | Food and Cosmetics | 06/07/2023 | Plant construction and design |